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Abstract
Background: Central Line-Associated BloodStream Infections (CLABSIs) are emerging challenge in Respiratory semi-
Intensive Care Units (RICUs). We evaluated efficacy of educational interventions on rate of CLABSIs and effects of
port protector as adjuvant tool.
Methods: Study lasted 18 months (9 months of observation and 9 of intervention). We enrolled patients with
central venous catheter (CVC): 1) placed during hospitalization in RICU; 2) already placed without signs of systemic
inflammatory response syndrome (SIRS) within 48 h after the admission; 3) already placed without evidence of
microbiologic contamination of blood cultures.
During interventional period we randomized patients into two groups: 1) educational intervention (Group 1) and 2)
educational intervention plus port protector (Group 2).
We focused on CVC-related sepsis as primary outcome. Secondary outcomes were the rate of CVC colonization and
CVC contamination.
Results: Eighty seven CVCs were included during observational period. CLABSIs rate was 8.4/1000 [10 sepsis (9
CLABSIs)]. We observed 17 CVC colonizations and 6 contaminations. Forty six CVCs were included during
interventional period. CLABSIs rate was 1.4/1000. 21/46 CVCs were included into Group 2, in which no CLABSIs or
contaminations were reported, while 2 CVC colonizations were found.
Conclusions: Our study clearly shows that both kinds of interventions significantly reduce the rate of CLABSIs. In
particular, the use of port protector combined to educational interventions gave zero CLABSIs rate.
Trial registration: NCT03486093 [ClinicalTrials.gov Identifier], retrospectively registered.
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intensive care unit
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Background
Central Line-Associated BloodStream Infections (CLAB-
SIs) are responsible for as many as 28,000 deaths in the
United States annually [1–7]. A recent analysis found
that 65–70% of CLABSIs could be prevented with the
proper institution of catheter care measures [8].
There are 2 main routes by which central venous cath-
eters (CVCs) become colonized: from bacteria contam-
inating the outside of the catheter either at the time of
insertion or after insertion (extraluminal) and/or by con-
tamination of the hub, catheter, or other administration
device (intraluminal). The extraluminal pathway pre-
dominates in the first week after CVC placement,
whereas the intraluminal mechanism is the more com-
mon pathway for CVCs that are > 1 week old [9, 10].
Several collaboratives have demonstrated the prevent-
ability of these infections [11, 12]. Educational interven-
tions decrease rates of CLABSIs [13]. In addition to
training, education, and surveillance, important preven-
tion practices include the use of chlorhexidine skin anti-
septics and maximal sterile barrier precautions at
catheter insertion [14, 15].
Other maintenance practices include hand hygiene be-
fore handling catheters or catheter sites, chlorhexidine
for skin antisepsis with dressing changes, and disinfect-
ing catheter hubs or injection ports with an appropriate
agent before accessing the catheter [16, 17].
Non antibiotic antiseptic locks (such as alcohol or tri-
sodium citrate), have also demonstrated some success in
reducing CLABSIs. In particular, alcohol-impregnated
port protectors and needleless neutral pressure connec-
tors significantly reduced rates of CLABSIs [18].
To date, in literature, no data exist on rate, risk factors
and prevention strategies of CLABSIs in RICUs. These
units usually work as “step-up” units within acute care
hospitals to manage patients with respiratory failure with
non-invasive ventilation [19, 20]. These units may pro-
vide multidisciplinary rehabilitation [21] and serve as a
bridge to home-care programs or long-term care facil-
ities [22]. Some of these RICUs may work also as “step
down” units for difficult to wean patients [23].
We performed a single-centre prospective study with
the aim to assess the efficacy of educational interven-
tions alone and combined with port protector as adju-
vant tool on rate of CLABSIs (primary outcome).
Secondary outcomes were the effects of previously men-
tioned interventions on rates of CVC colonizations and
contaminated blood cultures.
Methods
This study was approved by the Local Ethical Committee
of the Catholic University of the Sacred Heart in Rome,
Italy (Prot.n°5664) and it was performed according to
the Helsinki Declaration of Good Clinical Practice.
Three departments were involved: Respiratory semi-In
tensive Care Unit, Institute of Microbiology and Institute
of Infectious Diseases.
Participants
The study enrolled patients admitted to RICU from
April 2013 and it lasted 18 months. We chose three mu-
tually exclusive inclusion criteria were: 1) CVC was
placed during hospitalization in RICU; 2) CVC already
in place at admittance without signs of systemic inflam-
matory response syndrome (SIRS) during first 48 h from
admission to RICU [24]; 3) CVC already placed at ad-
mittance without evidence of microbiologic contamin-
ation of blood cultures.
Each patient gave written informed consent.
Patients enrolled underwent blood cultures sampling
whenever they showed SIRS signs.
SIRS is defined as 2 or more of the following vari-
ables: 1) fever of more than 38 °C (100.4 °F) or less
than 36 °C (96.8 °F), 2) heart rate of more than 90
beats per minute, 3) respiratory rate of more than 20
breaths per minute or arterial carbon dioxide tension
(PaCO2) of less than 32 mmHg, 4) abnormal white
blood cell count (> 12,000/μL or < 4000/μL or > 10%
immature [band] forms) [24, 25]. Septic shock was
defined as sepsis associated with organ dysfunction
and persistent hypotension despite volume replace-
ment [24, 25].
According to international guidelines [26–28], blood
cultures were collected simultaneously from both central
line and peripheral blood.
So doing, we identified five different mutually exclu-
sive conditions: 1) significant different time to positiviza-
tion of blood cultures (at least 2 h) between central line
sample and peripheral sample (sepsis related to CVC –
CLABSIs); 2) not significant different time to positiviza-
tion of blood cultures (sepsis not related to CVC); 3)
positive blood cultures from central line sample and
negative from peripheral one (CVC colonization); 4)
negative blood cultures from central line sample and
positive from peripheral one (contaminated blood cul-
tures); 5) negative blood cultures from both peripheral
and central line samples (SIRS not sustained by sepsis).
CVCs were removed when conditions 1 and 3 occurred.
Catheter tips were collected and prepared for subse-
quent microbiological analysis and identified microbial
species have been reported.
Each catheter was designated by type of vessel used
(peripheral versus central); site of insertion (subclavian,
femoral, internal jugular, peripheral, and Peripherally
Inserted Central Catheter [PICC]) [10, 16].
Moreover, for each patient, data concerning proven-
ance, parenteral nutrition, presence of tracheostomy
tube and mechanical ventilation were collected.
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Finally, in order to measure the severity of clinical
condition of each patient, we adopted APACHE III score
[29] and Charlson’s Comorbidity Index score [30].
Microbiological methods
The entire medical center is served by a central micro-
biology laboratory, which is open from 7:00 AM to 7:00
PM, Monday through Saturday.
For adult patients with suspected BSIs, the center’s
standard of care requires the sequential collection at
30-min intervals of at least three sets of aerobic and an-
aerobic BCs (CLSI). For each set, a 20-mL blood sample
is collected via a single venipuncture or intravascular
line access. Skin or access ports are disinfected with al-
cohol and povidone iodine.
The blood sample is used to inoculate one BACTEC
Plus Aerobic/F and Anaerobic bottles (10 mL of blood
each) (Becton Dickinson Instrument Systems, Sparks,
Md). The bottles are brought to the laboratory and incu-
bated up to 5 days in the BACTEC FX automated blood
culture instrument (Cultures arriving when the labora-
tory is closed are stored at room temperature in accord-
ance with manufacturers’ instructions). When the
growth index of a bottle was positive, broth aliquots
were collected for standard identification studies, which
entailed Gram staining (the results of which were imme-
diately reported to the patient’s physician), routine sub-
culture, and matrix-assisted laser desorption ionization–
time of flight (MALDI-TOF) mass spectrometry
(MALDI BioTyper, Bruker Daltonik GmbH, Leipzig,
Germany) analysis of culture samples, supplemented
when necessary with additional biochemical methods
and/or 16S rRNA gene sequencing [31, 32]. Antibiotic
susceptibility tests were performed using the Vitek 2 sys-
tem (bioMérieux, Marcy l’Etoile, France). Confirmatory
MIC testing for oxyimino-cephalosporins and carbapen-
ems was carried out by Etest (bioMérieux). Results were
interpreted according to the European Committee on
Antimicrobial Susceptibility Testing (EUCAST) break-
points (EUCAST table). Catheter tip cultures were per-
formed according to the method described by Maki et
al. [33].
Study design
The study was divided in two periods of equal duration
time (9 months): a preliminary prospective observational
period (phase I) and a subsequent prospective interven-
tional period (phase II).
Patients enrolled during phase I were the Treat 0
group. During phase II, two interventional strategies
have been adopted:
1. at the beginning of interventional study and then
every 45 days, physicians and nurses of RICU have
been trained and retrained to GAVECELT (“Long
Term Venous Central Lines” Open Group –
https://gavecelt.it/nuovo/) “bundle”
recommendations concerning the management of
CVC. The bundle includes: hand hygiene and
precautions for protection and safety, adequate
insertion site, echo-guided placement of central
venous line, use of clorexidine 2% for skin disinfec-
tion of insertion site chosen and subsequent con-
tinuous or discontinuous disinfection of exit site,
use of suture-less devices, use of transparent semi-
permeable dressing whenever applicable and imme-
diate removal of catheter when no longer needed.
Moreover, in order to reduce the use of unnecessary
catheters, we regularly evaluated the need for CVCs
for both patients admitted to RICU and patients
moved out of the ICU and unnecessary catheters
were promptly removed.
2. After the first training meeting, the use of Curos®
Disinfecting Port Protector for needleless valves
port-protector (CUROS, 70% isopropyl alcohol-
impregnated, Ivera Medical, San Diego, California,
US) has been introduced.
Patients ruled in during the interventional period have
been randomized into two groups:
1. patients with CVC managed by healthcare workers
trained/retrained to GAVECELT recommendations
(Treat 1 group).
2. Patients with CVC managed by healthcare workers
trained/retrained to GAVECELT recommendations
with the aid of port protector devices (Treat 2
group).
Curos® Disinfecting Port Protector is a passive dis-
infection device that luer-locks securely onto needle-
less IV ports to disinfect in 3 min. If not removed,
ports stay clean and protected for 7 days. The Curos®
is intended for use on swabbable luer access valves as
a disinfecting cleaner prior to line access and to act
as a physical barrier to contamination between line
accesses. Curos disinfects the valve three minutes
after application and acts as a physical barrier to con-
tamination for up to seven days if not removed.
Analysis
Description of the sample was made calculating mean
values and standard deviation for continuous vari-
ables, percentages for dichotomous or ordinal varia
bles.
Simple randomization was the method used (Stata ver-
sion 9, StataCorp LLC, USA).
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Regarding concealment, a centralized computer algo-
rithm was adopted to assign subjects to Treat 1 or Treat
2 group.
The head of nurses (MC) and physicians allocated to
the intervention groups (GP, DM, GM) were aware of
the allocated arm, outcome assessors and data analysts
(RI, GS, GMC, RT, TS) were kept blinded to the
allocation.
Overall catheter dwell time was reported. CLABSIs
rate expressed as number of sepsis related to CVC per
1000 days of catheter dwell time was computed. Data
concerning number of CVC colonizations, contaminated
blood cultures and negative blood cultures have been
also reported.
The primary analysis was a quasi-experimental design
comparing baseline rate of outcome measurements (the
rates of CLABSIs, CVC colonizations and contaminated
blood cultures) to the rates during the intervention.
Then, the same measurements were compared between
the two interventional groups (educational alone and
combined with port protector).
Incidence of primary and secondary outcomes were
analyzed using log rank test and Cox regression.
Variables included in the model were: type of treat-
ment (educational interventions and educational inter-
ventions + Curos compared to the observational
period), site of insertion, APACHE III score, Charlson
Comorbidity Index, provenance of patient, hospital
days before the admission to RICU, presence of
tracheostomy, length of stay on mechanical ventila-
tion, age and sex.
Results
One hundred thirty-two patients were enrolled: 86 dur-
ing the observational period (phase I) and 46 during
interventional period (phase II), the latter divided ran-
domly into two study groups: 25 in study group of edu-
cational interventions (Treat 1 group) and 21 in study
group of educational interventions + Curos (Treat 2
group) (see Consort 2010 Flow Diagram).
Table 1 shows demographic characteristics of study
population divided into three study groups. The three
study groups did not differ in severity of clinical con-
dition, assessed by APACHE III score and Charlson
Comorbidity index, percentage of patients on mech-
anical ventilation, also through tracheostomy. Instead,
there is a higher percentage of patients on parenteral
nutrition in study group 0. The central venous accesss
were divided in PICC, venous access placed in the
subclavian vein / internal jugular vein and venous ac-
cess placed in the femoral vein. Table 1 describes the
distribution of type of venous catheter in the three
study groups considered.
Table 2 describes rate of CLABSIs, colonizations of
CVCs and contaminated blood cultures during observa-
tional period (phase I) and interventional period (phase
II).
During the first period, rate of CLABSIs (expressed
as CLABSIs / 1000 catheter days of life) was 8.6.
The measures implemented during interventional
period led to a reduction of rate of both CLABSIs and
colonizations of venous catheters.
In particular, educational measures combined to de-
vice led to zero the cases of CLABSIs. The compari-
son between two periods has detected a reduction of
incidence of CLABSIs at the margin of significance
[log rank test, p = 0.0568]. Moreover, risk of CLABSIs
reduced during interventional period, with the hazard
ratio (HR) of 0.17 [95% Conf. Interval: 0.02–1.36, p =
0.096] [Cox regression – Breslow method] [Fig. 1].
Table 1 Demographic characteristics of the study population.
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Subsequently, we focused on patients with colonization
of venous catheter.
First, we performed univariate analysis (log-renk test)
to evaluate incidence and, subsequently, risk of
colonization according to treatment, excluding cases of
CLABSI and comparing patients with CVC colonization
with ones with contamination of blood cultures and
negativity of microbiological investigations (negative).
During prospective interventional period, implemented
treatments led to a reduction of incidence of colonization
[log rank test, p = 0.0635]. Moreover, risk of colonization
reduced in both treatment groups during interventional
period, with HR of 0.30 [95% Conf. Interval: 0.07–1.29]
for Treat 1 group (educational interventions) and HR of
0.33 [95% Conf. Interval: 0.07–1.45] for Treat 2 group
(educational interventions + Curos) [Cox regression –
Breslow method] [Fig. 2].
Subsequently, we evaluated the distribution of cases of
CVC colonization according to site of insertion and the
risk of colonization of CVC with Cox regression – Bre-
slow method analysis [Table 3].
It is possible to observe that risk of colonization of
CVC significantly reduced in both interventional groups
(HR: 0.07, 95% Conf. Interval: 0.01–0.51 for Treat 1
group – educational interventions; HR: 0.14, 95% Conf.
Interval: 0.02–0.83 for Treat 2 group – educational in-
terventions + Curos). Conversely, there was a signifi-
cantly increased risk of colonization of CVC for patients
to whom venous catheter was placed in subclavian / in-
ternal jugular vein and femoral vein with HR of 6.14 and
8.17, respectively.
Finally, we observed that use of educational measures
combined to application of device led to zero cases of
contaminated blood cultures [Table 2]. Nonetheless,
Table 2 The rate of CLABSIs, CVC colonizations and contaminations of blood cultures.
Fig. 1 Kaplan-Meier curves: estimates of occurrence of CLABSIs by treatment: interventional period (Treat 1 group) compared with observational
period (Treat 0 group)
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Fig. 2 Kaplan-Meier curves: estimates of occurrence of CVC colonization by treatment: interventional period (Treat 1 group and Treat 2 group)
compared with observational period (Treat 0 group)
Table 3 CVC colonizations according to the site of insertion.
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Fig. 3 Kaplan-Meier curves: estimates of occurrence of CVC contamination by treatment: interventional period (Treat 1 group) compared with
observational period (Treat 0 group)
Table 4 Distribution of CLABSI organisms, CVC colonization organisms and contaminated blood culture organisms.
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there was no significant reduction between two study
periods [log rank test, p = 0.6139] [Fig. 3].
The organisms recovered are presented in Table 4.
Discussion
In this prospective randomized study, we explored rate
of CLABSIs, CVC colonizations and contaminated blood
cultures before and after introduction of educational in-
terventions alone and combined with port protector as
adjuvant tool.
To the best of our knowledge, this is the first study
performed in a RICU.
Three main conclusions can be extracted from this
work. (i) educational interventions combined to Curos®
Disinfecting Port Protector led to zero rate of CLABSIs.
Additionally, risk of CLABSIs reduced during interven-
tional period. (ii) The measures implemented reduced
also rate of colonizations of the venous catheters. Lastly,
(iii) risk of colonization of CVC increased for patients to
whom venous catheter was placed in subclavian / in-
ternal jugular vein and femoral vein.
The importance of the education of healthcare
personnel regarding the indications for intravascular
catheter use, proper procedures for the insertion and
maintenance of intravascular catheters, and appropriate
infection control measures to prevent intravascular
catheter-related infections is well known [34]. Further-
more, previous studies also highlighted the need of peri-
odical assessment of knowledge of and adherence to
guidelines for all personnel involved in insertion and
maintenance of intravascular catheters [34, 35].
Recently, Sweet MA et al. [18] showed that
alcohol-impregnated port protectors and needleless neu-
tral pressure connectors significantly reduced rates of
CLABSIs and contaminated blood cultures in an oncol-
ogy patient population. Similar results were reported by
Wright MO et al., [36] where disinfection cap with 70%
alcohol reduced line contamination, organism density,
and CLABSIs.
The novelty of our study consists in performing a pro-
spective study with the specific aim of assessing effects
of educational interventions combined to
alcohol-impregnated port protector on rate and risk of
CLABSIs, CVC colonizations and contaminated blood
cultures in a clinical setting at high risk of bloodstream
infections.
This strategy allowed us to zero rate of CLABSIs (from
8.6 CLABSIs / 1000 catheter days of life to 2.6 with edu-
cational interventions and zero with educational inter-
ventions combined to port protector). Our experience
demonstrates that this goal, warmely supported by inter-
national experts [10], is feasible.
Another interesting observation is that this preventive
strategy reduced also risk of CLABSIs (83% reduction).
Strong evidence exists in literature about reduction of
risk for infection following standardization of aseptic
care [34, 35]. Moreover, specialized “IV teams” reduced
incidence of catheter-related bloodstream infections, as-
sociated complications, and costs [37].
In our hospital, there is a specialized IV team dedi-
cated to the CVC placement. Therefore, we preferred to
focus our attention on management of catheter essen-
tialy based on training and retraining of physicians and
nurses of the RICU to GAVECELT “bundle”
recommendations.
The reduction of both rate and risk of CLABSIs con-
firms previous reports [9, 38] asserting the catheter hub
colonization as the primary pathogenetic explanation of
central catheter infections after the insertion (intralum-
inal causal pathway).
In our study, both treatments caused a decrease of rate
of CVC colonizations (70% reduction with educational
interventions and 67% reduction with educational inter-
ventions combined to port protector).
This is in line with the observations by Wright MO,
who found that the catheter hub contamination was sig-
nificantly less likely to occur, and, when it did occur, the
number of recovered organisms were significantly fewer
with the use of the disinfection cap [36].
Subsequently, we observed that risk of colonization of
CVC significantly reduced in both interventional groups
(93% reduction with educational interventions and 86%
reduction with educational interventions and Curos).
Conversely, there was a significantly increased risk of
colonization of CVC for patients to whom venous cath-
eter was placed in subclavian / internal jugular vein (HR
of 6.14) and femoral vein (HR of 8.17) compared to pa-
tients to whom a PICC was placed.
Our study confirms that site at which a catheter is
placed influences the subsequent risk for
catheter-related infection. The influence of site on the
risk for catheter infections is related in part to the dens-
ity of local skin flora.
As far as we know, this is the first study that prospect-
ively compared infection rates for catheters placed in
jugular, subclavian, femoral and peripheral veins (PICC).
In agreement with literature [39], our results highlight
that femoral catheters have highest colonization rates.
Finally, we observed that educational measures com-
bined to port protector led to zero the cases of contami-
nated blood cultures.
This study has some limitations. First, sample size is
apparently limited if compared to study period (18
months). Our RICU works essentially as “step down”
unit for difficult to wean patients coming from our ICUs
(more than 50% of enrolled patients). Moreover, our unit
provides multidisciplinary rehabilitation and serves as a
bridge to home-care programs or long-term care
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facilities. Mean length of stay in our unit was 33 days
and this partially explains the number of enrolled
patients.
Furthermore, number of patients enrolled during
interventional period was lower than that of the observa-
tional period. We believe that this apparent limitation
reflects a better selection of patients who will benefit
from the use of catheters due to educational training/
retraining, thus this finding can be considered a positive
result of the study.
Conclusions
This study shows that synergistic effects of educational
interventions and use of Curos® Disinfecting Port Pro-
tector allow to zero rate and reduce the risk of CLABSIs
in a Respiratory semi-Intensive Care Unit.
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